Several studies have analyzed CK18 in different chronic liver disease and healthy controls, including chronic viral hepatitis [14, 28], autoimmune hepatitis and cholestatic liver diseases [12], as well as NAFLD and NASH [11, 29]. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.